Variant report
Variant | nsv974265 |
---|---|
Chromosome Location | chr13:88558371-88599404 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:95255999..95256872-chr13:88573166..88573666,2 | Hela-S3 | cervix: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000138180 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559611911 | chr13:88572209-88572210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150474871 | chr13:88572227-88572228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563863584 | chr13:88572237-88572238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575663822 | chr13:88572260-88572261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542684362 | chr13:88572395-88572396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111428061 | chr13:88572458-88572459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147748981 | chr13:88572486-88572487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537926153 | chr13:88572529-88572530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528457941 | chr13:88572545-88572546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567575820 | chr13:88572608-88572609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540975101 | chr13:88572622-88572623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556185175 | chr13:88572650-88572651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375176537 | chr13:88572674-88572675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115365660 | chr13:88572691-88572692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141078148 | chr13:88572717-88572718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551304514 | chr13:88572735-88572736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192098356 | chr13:88572793-88572794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530551242 | chr13:88572801-88572802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549086841 | chr13:88572895-88572896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs367880045 | chr13:88572896-88572897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535416310 | chr13:88572897-88572898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146931177 | chr13:88572924-88572925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138004009 | chr13:88572940-88572941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546864352 | chr13:88572952-88572953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554035447 | chr13:88573015-88573016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552954830 | chr13:88573031-88573032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184284419 | chr13:88573048-88573049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116830054 | chr13:88573060-88573061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572217593 | chr13:88573088-88573089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539283793 | chr13:88573105-88573106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149493692 | chr13:88573139-88573140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs528612656 | chr13:88573165-88573166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575771379 | chr13:88573220-88573221 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs143121103 | chr13:88573222-88573223 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs554640037 | chr13:88573246-88573247 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs188578557 | chr13:88573250-88573251 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs545995964 | chr13:88573267-88573268 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs540242848 | chr13:88573272-88573273 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs76790046 | chr13:88573298-88573299 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs148239753 | chr13:88573385-88573386 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs141267570 | chr13:88573419-88573420 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs372462539 | chr13:88573487-88573488 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs530718101 | chr13:88573494-88573495 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs549144046 | chr13:88573512-88573513 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs180933283 | chr13:88573523-88573524 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs202033565 | chr13:88573535-88573536 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs557655554 | chr13:88573557-88573558 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs528150230 | chr13:88573572-88573573 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs118009349 | chr13:88573639-88573640 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs571193273 | chr13:88573703-88573704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Breast cancer | 17142309 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:88572200-88573000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr13:88572200-88573800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr13:88572400-88572600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr13:88572400-88573600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr13:88574400-88574800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr13:88587800-88588200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr13:88593200-88593400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr13:88593400-88593800 | Enhancers | Fetal Lung | lung |
9 | chr13:88593400-88594400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr13:88593600-88595000 | Enhancers | Fetal Kidney | kidney |
11 | chr13:88593800-88594200 | Weak transcription | Fetal Lung | lung |
12 | chr13:88594000-88595000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr13:88594200-88595200 | Enhancers | Fetal Lung | lung |
14 | chr13:88594400-88595000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr13:88595000-88596000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr13:88596200-88596400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |